Subcutaneous ICD Matches Standard ICD In Controlled Trial
This article was originally published in The Gray Sheet
Executive Summary
Short-term results in a study of Boston Scientific's S-ICD device show promise, but also point to room for improvement.
You may also be interested in...
Subcutaneous ICD Matches Conventional Defibrillators In Registry
Boston Scientific’s S-ICD subcutaneous implantable cardioverter defibrillator performed well in the EFFORTLESS registry, with clinical event rates and inappropriate shock rates similar to those reported for conventional ICDs in a real-world context.
Percutaneous Intravascular Defibrillator Could Avert Common ICD Complications
A percutaneous intravascular cardioverter-defibrillator matched a conventional ICD in a randomized comparison of defibrillation thresholds. The authors of the study believe the PICD could reduce many of the complications associated with conventional defibrillators.
New Products In Brief
Recent new product launches and approvals include Boston Scientific’s novel S-ICD subcutaneous implantable cardioverter defibrillator, Globus Medical’s Secure-C artificial cervical disc and ConforMIS’ next-generation iTotal G2 total knee replacement.